The Compendium of Cancer Genome Aberrations: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and others with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' | '''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and others with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' | ||
* Join the CCGA community! If you would like to contribute as an author, please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. | *Join the CCGA community! If you would like to contribute as an author, please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. | ||
* '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' for more information or suggestions for updates. | *'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' for more information or suggestions for updates. | ||
* Meet our editorial '''<u>[[Leadership]]</u>'''. | *Meet our editorial '''<u>[[Leadership]]</u>'''. | ||
* For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''. | *For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''. | ||
*Join us on Twitter! [https://twitter.com/ccgawiki @ccgawiki]. | |||
{{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''. | {{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''. | ||